PDC and colitis: Of note, while both prolyl hydroxylase (PHD) and von Hipple Lindau inhibition result in HIF activation, PHD inhibitors or genetic disruption of PHDs have been shown to effectively activate HIF-1α and to improve gut barrier function in murine colitis models.13